How should I write an ultrasound order for a pelvic or uterine mass in an adult female patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Write an Ultrasound Order for Pelvic or Uterine Mass

Order a transvaginal ultrasound with transabdominal ultrasound and color Doppler evaluation of the pelvis. This combined approach is the most useful modality for evaluating pelvic and uterine masses 1.

Specific Order Components

Your ultrasound order should include the following elements:

Primary Imaging Modality

  • Transvaginal ultrasound (TVUS) combined with transabdominal ultrasound (TAUS) 1
  • This combination provides optimal visualization of pelvic structures 2

Essential Add-On

  • Color or power Doppler imaging must be included 1
  • Doppler evaluates vascularity of any solid components, which is critical for characterizing the mass 1

Required Information in the Ultrasound Report

The radiologist should document 3:

  • Size and laterality (unilateral vs bilateral)
  • Organ of origin (uterine vs ovarian vs adnexal)
  • Septation thickness if present
  • Presence of excrescences (papillary projections)
  • Internal solid components
  • Vascular flow distribution pattern (via Doppler)
  • Presence or absence of ascites

This standardized reporting is essential for calculating risk of malignancy scores 3.

Special Circumstances

If Transvaginal Approach Cannot Be Tolerated

  • Order transabdominal ultrasound alone 1
  • The bladder must be full to provide the best acoustic window 1

When Initial Ultrasound Is Indeterminate

If the mass remains indeterminate after initial ultrasound characterization:

  • MRI pelvis with IV contrast is the next imaging study of choice 1
  • Contrast-enhanced MRI performs superiorly to both ultrasound and noncontrast MRI because it confirms the presence of internal enhancing soft tissue components 1
  • CT is not useful for further characterization of indeterminate adnexal masses 1

Clinical Context Matters

Postmenopausal Patients

  • Simple cysts >3 cm warrant follow-up (or >5 cm if exceptionally well-visualized) 1
  • Simple unilocular cysts carry near-zero malignancy risk regardless of size or menopausal status 1

Premenopausal Patients

  • The same imaging approach applies 1
  • Simple cysts have an absolute 3-year ovarian cancer risk of 0-0.5 cases per 10,000 women 1

Common Pitfalls to Avoid

  • Don't order CT for initial evaluation - ultrasound is superior for tissue characterization and is the primary imaging modality 2
  • Don't forget Doppler - vascular flow patterns are critical for risk stratification 1
  • Don't accept incomplete reports - ensure all standardized elements are documented to properly assess malignancy risk 3
  • Don't order MRI first - it's not first-line imaging, reserve it for indeterminate cases 1

References

Research

Ultrasonography evaluation of pelvic masses.

Radiologic clinics of North America, 2014

Research

Initial evaluation and referral guidelines for management of pelvic/ovarian masses.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.